IJMS | Free Full-Text | Targeting NF-κB-Inducing Kinase (NIK) in Immunity, Inflammation, and Cancer
Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small molecules for the treatment of human diseases - RSC Medicinal Chemistry (RSC Publishing)
Negative Feedback in Noncanonical NF-κB Signaling Modulates NIK Stability Through IKKα-Mediated Phosphorylation | Science Signaling
Recombinant Human NFkB Inducing Kinase NIK protein (ab61262) | Abcam
NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176 | PNAS
Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small molecules for the treatment of human diseases - RSC Medicinal Chemistry (RSC Publishing) DOI:10.1039/D0MD00361A
Kinase Selectivity Profiling Systems—STE and TKL
NIK as a Druggable Mediator of Tissue Injury: Trends in Molecular Medicine
Cells | Free Full-Text | Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets
Possible mechanism of the effect of aging and heptadecane on the... | Download Scientific Diagram
Nck-Interacting Ste20 Kinase Couples Eph Receptors to c-Jun N-Terminal Kinase and Integrin Activation | Molecular and Cellular Biology
Structure-Based Design of Tricyclic NF-κB Inducing Kinase (NIK) Inhibitors That Have High Selectivity over Phosphoinositide-3-kinase (PI3K) | Journal of Medicinal Chemistry
NIK Antibody | Cell Signaling Technology
NIK as a Druggable Mediator of Tissue Injury: Trends in Molecular Medicine
NFkB Inducing Kinase NIK Antibody – Bioss
The discovery of quinoline derivatives, as NF-κB inducing kinase (NIK) inhibitors with anti-inflammatory effects in vitro, low toxicities against T cell growth - ScienceDirect
NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus | Nature Communications
NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176 | PNAS
NIK as a Druggable Mediator of Tissue Injury: Trends in Molecular Medicine
Frontiers | NF-κB Inducing Kinase Regulates Intestinal Immunity and Homeostasis
Non-canonical NF-κB signaling pathway | Cell Research
Frontiers | The Therapeutic Potential of Targeting NIK in B Cell Malignancies
Functional interplay between NF-κB-inducing kinase and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma | Haematologica